333 related articles for article (PubMed ID: 12684801)
1. Pancreaticobiliary maljunction: pathophysiological and clinical aspects and the impact on biliary carcinogenesis.
Matsumoto Y; Fujii H; Itakura J; Matsuda M; Yang Y; Nobukawa B; Suda K
Langenbecks Arch Surg; 2003 Apr; 388(2):122-31. PubMed ID: 12684801
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in pancreaticobiliary maljunction.
Matsumoto Y; Fujii H; Itakura J; Matsuda M; Nobukawa B; Suda K
J Hepatobiliary Pancreat Surg; 2002; 9(1):45-54. PubMed ID: 12021897
[TBL] [Abstract][Full Text] [Related]
3. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy.
Funabiki T; Matsubara T; Miyakawa S; Ishihara S
Langenbecks Arch Surg; 2009 Jan; 394(1):159-69. PubMed ID: 18500533
[TBL] [Abstract][Full Text] [Related]
4. Biliary carcinogenesis in pancreaticobiliary maljunction.
Kamisawa T; Kuruma S; Chiba K; Tabata T; Koizumi S; Kikuyama M
J Gastroenterol; 2017 Feb; 52(2):158-163. PubMed ID: 27704265
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Nagai M; Watanabe M; Iwase T; Yamao K; Isaji S
World J Surg; 2002 Jan; 26(1):91-8. PubMed ID: 11898040
[TBL] [Abstract][Full Text] [Related]
6. Pancreaticobiliary maljunction.
Kamisawa T; Takuma K; Anjiki H; Egawa N; Kurata M; Honda G; Tsuruta K; Sasaki T
Clin Gastroenterol Hepatol; 2009 Nov; 7(11 Suppl):S84-8. PubMed ID: 19896105
[TBL] [Abstract][Full Text] [Related]
7. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction.
Masuhara S; Kasuya K; Aoki T; Yoshimatsu A; Tsuchida A; Koyanagi Y
J Hepatobiliary Pancreat Surg; 2000; 7(2):198-205. PubMed ID: 10982614
[TBL] [Abstract][Full Text] [Related]
8. Pancreatobiliary disorders associated with pancreaticobiliary maljunction.
Kamisawa T; Honda G; Kurata M; Tokura M; Tsuruta K
Dig Surg; 2010; 27(2):100-4. PubMed ID: 20551651
[TBL] [Abstract][Full Text] [Related]
9. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
[TBL] [Abstract][Full Text] [Related]
10. Risk of bile duct carcinogenesis after excision of extrahepatic bile ducts in pancreaticobiliary maljunction.
Kobayashi S; Asano T; Yamasaki M; Kenmochi T; Nakagohri T; Ochiai T
Surgery; 1999 Nov; 126(5):939-44. PubMed ID: 10568195
[TBL] [Abstract][Full Text] [Related]
11. Pancreaticobiliary maljunction and choledochal cysts: from embryogenesis to therapeutics aspects.
Le Roy B; Gagnière J; Filaire L; Fontarensky M; Hordonneau C; Buc E
Surg Radiol Anat; 2016 Nov; 38(9):1053-1060. PubMed ID: 27003810
[TBL] [Abstract][Full Text] [Related]
12. Preferable operative age of choledochal dilation types to prevent patients with pancreaticobiliary maljunction from developing biliary tract carcinogenesis.
Kobayashi S; Ohnuma N; Yoshida H; Ohtsuka Y; Terui K; Asano T; Ryu M; Ochiai T
Surgery; 2006 Jan; 139(1):33-8. PubMed ID: 16364715
[TBL] [Abstract][Full Text] [Related]
13. Forty-year experience with flow-diversion surgery for patients with congenital choledochal cysts with pancreaticobiliary maljunction at a single institution.
Takeshita N; Ota T; Yamamoto M
Ann Surg; 2011 Dec; 254(6):1050-3. PubMed ID: 21659852
[TBL] [Abstract][Full Text] [Related]
14. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction.
Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F
J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832
[TBL] [Abstract][Full Text] [Related]
15. Pancreaticobiliary maljunction and biliary cancer.
Kamisawa T; Kuruma S; Tabata T; Chiba K; Iwasaki S; Koizumi S; Kurata M; Honda G; Itoi T
J Gastroenterol; 2015 Mar; 50(3):273-9. PubMed ID: 25404143
[TBL] [Abstract][Full Text] [Related]
16. Pancreas divisum in pancreaticobiliary maljunction.
Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A; Matsukawa M
Hepatogastroenterology; 2008; 55(81):249-53. PubMed ID: 18507118
[TBL] [Abstract][Full Text] [Related]
17. Cancer of the gallbladder associated with pancreaticobiliary maljunction without bile duct dilatation in a european patient.
Tuech JJ; Pessaux P; Aube C; Regenet N; Cervi C; Bergamaschi R; Arnaud JP
J Hepatobiliary Pancreat Surg; 2000; 7(3):336-8. PubMed ID: 10982637
[TBL] [Abstract][Full Text] [Related]
18. Pancreaticobiliary maljunction and congenital biliary dilatation.
Kamisawa T; Kaneko K; Itoi T; Ando H
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):610-618. PubMed ID: 28691687
[TBL] [Abstract][Full Text] [Related]
19. Surgical strategy for patients with pancreaticobiliary maljunction without choledocal dilatation.
Funabiki T; Matsubara T; Ochiai M; Marugami Y; Sakurai Y; Hasegawa S; Imazu H
Keio J Med; 1997 Dec; 46(4):169-72. PubMed ID: 9444927
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of pancreaticobiliary maljunction in children.
Ono S; Fumino S; Iwai N
Surg Today; 2011 May; 41(5):601-5. PubMed ID: 21533929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]